The NAD+ 1000mg & Retatrutide: The UK Innovation in Metabolic Health
Emerging data from the UK are generating considerable buzz surrounding the potential pairing of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This intriguing approach aims to target multiple facets of metabolic disorder, potentially offering a notewort